Stocks
ImageneBio, Inc.IMA
NASDAQHealthcareBiotechnology$4.72
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing targeted therapies for oncology and rare diseases. Its lead programs focus on precision medicines with biomarker-driven patient selection, positioning it among emerging players in the precision oncology space. Investors track the company for its pipeline catalysts and potential partnerships with larger pharmaceutical firms.
52W Range: $3.94-$9.10
Congressional Interest in ImageneBio, Inc. (IMA)
No congressional trades have been disclosed for ImageneBio, Inc. (IMA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IMA?
No congressional trades found for this stock.